SCHEMBL8554233

SCHEMBL8554233

Cc1ccnc(N2CCN(C(=O)Cc3c(C)n4c5c(cccc35)CCCC4)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.53
KDM4E B2RXH2 8/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HSD17B10 Q99714 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
TSHR P16473 1/20 0.45
PARP1 P09874 1/20 0.45
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
CPT2 P23786 1/20 0.42
CPT1A P50416 1/20 0.42
CPT1B Q92523 1/20 0.42
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8552282 0.89 ALOX5 (0.59) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL9304984 0.87 ALOX5 (0.45) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL8556392 0.85 ALOX5 (0.59) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL8554776 0.83 ALOX5 (0.73) ALOX5HSD17B10ALDH1A1HTR2AHTR2C
SCHEMBL8557862 0.82 ALOX5 (0.55) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL8557855 0.82 ALOX5 (0.55) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL8554000 0.82 ALOX5 (0.55) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL8555946 0.82 ALOX5 (0.71) ALOX5HSD17B10ALDH1A1HTR2AHTR2C
SCHEMBL8553132 0.81 ALOX5 (0.55) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL8554489 0.81 PARP1 (0.42) ALOX5KDM4ESMN1; SMN2HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0529452-B1 1,7-Condensed 3-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SOLVAY PHARM GMBH (DE) 1998-11-11 EP disclosed
EP-0529452-A2 1,7-Condensed 2-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them Kali-Chemie Pharma GmbH (DE) 1993-03-03 EP disclosed